GRISENDI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 15.267
EU - Europa 8.139
AS - Asia 6.359
SA - Sud America 988
Continente sconosciuto - Info sul continente non disponibili 295
AF - Africa 150
OC - Oceania 54
Totale 31.252
Nazione #
US - Stati Uniti d'America 14.904
SE - Svezia 2.339
IT - Italia 2.211
SG - Singapore 2.072
CN - Cina 1.515
GB - Regno Unito 1.387
VN - Vietnam 732
HK - Hong Kong 720
BR - Brasile 698
DE - Germania 570
BD - Bangladesh 317
RU - Federazione Russa 312
FI - Finlandia 267
FR - Francia 258
UA - Ucraina 176
CA - Canada 174
TR - Turchia 154
ID - Indonesia 149
KR - Corea 142
IN - India 125
MX - Messico 96
AR - Argentina 92
NL - Olanda 92
BG - Bulgaria 84
IE - Irlanda 64
JP - Giappone 60
IQ - Iraq 56
BE - Belgio 55
AU - Australia 52
PL - Polonia 50
ES - Italia 49
EC - Ecuador 44
ZA - Sudafrica 43
VE - Venezuela 41
PK - Pakistan 37
AE - Emirati Arabi Uniti 35
CO - Colombia 32
CL - Cile 30
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
MY - Malesia 24
AL - Albania 23
AT - Austria 23
CH - Svizzera 22
LT - Lituania 22
RO - Romania 20
MA - Marocco 19
JO - Giordania 18
NP - Nepal 18
PH - Filippine 18
SA - Arabia Saudita 17
KE - Kenya 16
DZ - Algeria 15
EG - Egitto 15
PE - Perù 15
PT - Portogallo 15
IL - Israele 14
IR - Iran 14
UY - Uruguay 14
BZ - Belize 13
CR - Costa Rica 13
KZ - Kazakistan 11
OM - Oman 11
PY - Paraguay 11
AZ - Azerbaigian 10
JM - Giamaica 10
TN - Tunisia 10
DO - Repubblica Dominicana 9
MD - Moldavia 9
RS - Serbia 9
ET - Etiopia 8
PA - Panama 8
BO - Bolivia 7
BY - Bielorussia 7
LB - Libano 7
NI - Nicaragua 7
SI - Slovenia 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
DK - Danimarca 6
EE - Estonia 6
GT - Guatemala 6
SN - Senegal 6
BB - Barbados 5
CY - Cipro 5
GR - Grecia 5
HN - Honduras 5
LK - Sri Lanka 5
MT - Malta 5
SY - Repubblica araba siriana 5
HR - Croazia 4
HU - Ungheria 4
NG - Nigeria 4
PR - Porto Rico 4
PS - Palestinian Territory 4
AM - Armenia 3
GE - Georgia 3
GY - Guiana 3
KG - Kirghizistan 3
Totale 30.906
Città #
Ashburn 1.809
Stockholm 1.796
Singapore 1.400
Fairfield 1.345
Santa Clara 1.263
Southend 798
San Jose 787
Chandler 745
Hong Kong 699
Woodbridge 697
Houston 616
Council Bluffs 504
Seattle 487
Cambridge 438
Ann Arbor 422
Wilmington 422
Nyköping 346
Hefei 328
Beijing 318
Modena 315
Los Angeles 297
New York 296
London 273
Dearborn 263
Jacksonville 255
Ho Chi Minh City 224
Bologna 222
Helsinki 200
Hanoi 190
Milan 185
Chicago 163
The Dalles 161
Munich 136
Seoul 133
San Diego 131
Jakarta 121
Frankfurt am Main 107
Shanghai 99
Princeton 85
Lauterbourg 84
Dallas 81
Buffalo 79
Moscow 79
Sofia 78
Izmir 77
São Paulo 75
Parma 68
Fremont 63
Rome 63
Orem 62
Eugene 58
Columbus 57
Dublin 57
Boardman 56
Phoenix 53
Salt Lake City 53
Brussels 48
Montreal 44
Atlanta 43
Tokyo 43
Bremen 42
Mexico City 40
Guangzhou 38
Toronto 37
Warsaw 37
Reggio Emilia 35
Da Nang 34
Denver 34
Nuremberg 33
Chennai 32
Hillsboro 31
San Giuliano Milanese 31
Falls Church 30
Brooklyn 29
Haiphong 26
Johannesburg 26
Redwood City 26
Tampa 25
Amsterdam 24
Elk Grove Village 24
Grafing 23
Manchester 23
Poplar 23
Rio de Janeiro 23
San Francisco 23
Des Moines 22
Florence 22
Lancaster 22
Norwalk 22
Baghdad 21
Boston 21
Naples 21
Ravenna 21
Redondo Beach 21
Sydney 21
Mumbai 20
Portsmouth 20
Tashkent 20
Newark 18
Turku 18
Totale 21.456
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.237
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 518
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish 510
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 492
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 467
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 445
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 441
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 436
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 433
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 432
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 418
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 411
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 411
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 403
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 398
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 395
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 386
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 385
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 375
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 373
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 373
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 360
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro 359
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 359
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 354
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 352
Tumor Stroma Manipulation By MSC 349
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 345
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 344
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 341
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 340
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 338
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 332
Detection of microparticles from human red blood cells by multiparametric flow cytometry 331
An adoptive immuno-gene therapy approach targeting neuroblastoma. 330
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 328
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 326
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 321
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 317
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 317
GD2 CAR T cells against human glioblastoma 306
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 302
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 302
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 300
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 299
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 294
Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors 290
IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation 288
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 287
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review 285
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 284
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 284
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 283
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 272
Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis 270
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 270
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 267
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 263
Scleral ossicles as natural biomaterials on which vascular-like network is promoted from Mouse Aortic Endothelial cells (MAECs): preliminary results 259
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 258
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 257
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models 256
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 256
Challenging the efficacy of checkpoint inhibitors: a new 3D model for a precision medicine approach. 253
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma 252
Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9) 252
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. 251
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 247
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 243
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells 243
Cancer stem cells and their microenvironment. 243
New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells. 240
Stem cells and lung cancer : between advanced diagnostics and new therapeutics. 238
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 234
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico 232
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 229
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 228
Sarcomas as a mise en abyme of Mesenchymal Stem Cells; exploiting interrelationships for cell mediated anticancer therapy 221
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 214
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study 214
Refining GMP-manufactured density gradient media for optimised mesenchymal stromal/stem cell isolation and expansion. 208
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance 205
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine 201
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 195
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 195
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 189
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 189
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 185
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence 182
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 176
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 169
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 169
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study 166
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro 164
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 150
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 150
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy 145
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 145
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations 126
Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer 123
Totale 31.080
Categoria #
all - tutte 113.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.643 0 0 0 90 78 123 177 145 216 163 414 237
2022/20232.267 259 278 189 241 231 265 63 216 260 26 124 115
2023/20241.494 101 88 113 155 280 181 102 138 36 51 71 178
2024/20255.067 144 90 184 372 850 859 501 263 527 254 402 621
2025/202611.389 633 332 669 1.134 1.592 559 1.170 470 2.678 993 719 440
2026/20271.858 263 547 598 450 0 0 0 0 0 0 0 0
Totale 31.252